摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-Hydroxyethyl)-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1, 2-thiazine-6-sulfonamide 1,1-dioxide | 171273-06-6

中文名称
——
中文别名
——
英文名称
2-(2-Hydroxyethyl)-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1, 2-thiazine-6-sulfonamide 1,1-dioxide
英文别名
2-(2-Hydroxyethyl)-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide;2-(2-hydroxyethyl)-3-(morpholin-4-ylmethyl)-1,1-dioxothieno[3,2-e]thiazine-6-sulfonamide
2-(2-Hydroxyethyl)-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1, 2-thiazine-6-sulfonamide 1,1-dioxide化学式
CAS
171273-06-6
化学式
C13H19N3O6S3
mdl
——
分子量
409.508
InChiKey
JHTLZMXVNYOKAY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.1
  • 重原子数:
    25
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    175
  • 氢给体数:
    2
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(2-Hydroxyethyl)-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1, 2-thiazine-6-sulfonamide 1,1-dioxide氯化亚砜 作用下, 以 四氢呋喃乙酸乙酯N,N-二甲基甲酰胺 为溶剂, 反应 3.0h, 生成 2',2'-Dioxospiro[1,4-oxazinan-4-ium-4,11'-2lambda6,4-dithia-1-aza-11-azoniatricyclo[7.4.0.03,7]trideca-3(7),5,8-triene]-5'-sulfonamide;chloride
    参考文献:
    名称:
    Quaternary ammonium substituted thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides: Potential membrane-impermeable inhibitors of carbonic anhydrase
    摘要:
    Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides, which have a quaternary ammonium moiety incorporated into their structures, were synthesized. All of the quaternary ammonium salts prepared in the present study are potent inhibitors of both human carbonic anhydrase-II and recombinant human carbonic anhydrase-IV; they are significantly more potent as inhibitors of these carbonic anhydrase isozymes than the previously reported inhibitor quatemary ammonium homosulfanilamide. By virtue of the permanent cationic charge on these compounds they are anticipated to be membrane-impermeable inhibitors of carbonic anhydrase. Spiro quaternary ammonium compounds, such as 15 and 16, when formed by intracellular cyclization following transport of a suitable precursor molecule, such as 14, may be selective prolonged inhibitors of cytosolic carbonic anhydrase due to intracellular entrapment. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2005.10.054
  • 作为产物:
    描述:
    2-(2-Methoxyethyl)-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide氢溴酸碳酸氢钠 作用下, 以 为溶剂, 以56%的产率得到2-(2-Hydroxyethyl)-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1, 2-thiazine-6-sulfonamide 1,1-dioxide
    参考文献:
    名称:
    Carbonic anhydrase inhibitors
    摘要:
    披露了具有以下公式的化合物:本发明涉及公式I的化合物:##STR1## 其中G,J以及它们所连接的噻吩环上的两个原子形成一个六元环,选自##STR2## 这些化合物作为碳酸酐酶抑制剂是有用的。
    公开号:
    US05538966A1
点击查看最新优质反应信息

文献信息

  • US5538966A
    申请人:——
    公开号:US5538966A
    公开(公告)日:1996-07-23
  • Quaternary ammonium substituted thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides: Potential membrane-impermeable inhibitors of carbonic anhydrase
    作者:Jesse A. May、Abdelmoula Namil、Hwang-Hsing Chen、Anura P. Dantanarayana、Brian Dupré、John C. Liao
    DOI:10.1016/j.bmc.2005.10.054
    日期:2006.3
    Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides, which have a quaternary ammonium moiety incorporated into their structures, were synthesized. All of the quaternary ammonium salts prepared in the present study are potent inhibitors of both human carbonic anhydrase-II and recombinant human carbonic anhydrase-IV; they are significantly more potent as inhibitors of these carbonic anhydrase isozymes than the previously reported inhibitor quatemary ammonium homosulfanilamide. By virtue of the permanent cationic charge on these compounds they are anticipated to be membrane-impermeable inhibitors of carbonic anhydrase. Spiro quaternary ammonium compounds, such as 15 and 16, when formed by intracellular cyclization following transport of a suitable precursor molecule, such as 14, may be selective prolonged inhibitors of cytosolic carbonic anhydrase due to intracellular entrapment. (c) 2005 Elsevier Ltd. All rights reserved.
  • Carbonic anhydrase inhibitors
    申请人:Alcon Laboratories, Inc.
    公开号:US05538966A1
    公开(公告)日:1996-07-23
    Compounds of the following formula are disclosed: Compounds of Formula I are the topic of this invention: ##STR1## Wherein G, J and the two atoms of the thiophene ring to which they are attached form a six-membered ring chosen from ##STR2## The compounds are useful as carbonic anhydrase inhibitors.
    披露了具有以下公式的化合物:本发明涉及公式I的化合物:##STR1## 其中G,J以及它们所连接的噻吩环上的两个原子形成一个六元环,选自##STR2## 这些化合物作为碳酸酐酶抑制剂是有用的。
查看更多

同类化合物

布林左胺 布林佐胺盐酸盐 布林佐胺杂质E 布林佐胺杂质C 布林佐胺杂质2 布林佐胺中间体 布林佐胺 布林佐胺 N-去乙基布林佐胺 6-氯-4-羟基-3,4-二氢-2H-噻吩并[3,2-e][1,2]噻嗪1,1-二氧化物 6-氯-2,3-二氢-4H-噻吩并[3,2-e]-1,2-噻嗪-4-酮1,1-二氧化物 6-乙酰基-1H-噻吩并[2,3-b][1,4]噻嗪-2(3H)-酮 4-羟基-2-甲基-2H-噻吩并[2,3-E]-1,2-噻嗪-3-甲酰胺1,1-二氧化物 3,4-二氢-4-羟基-2H-噻吩并[3,2-e]-1,2-噻嗪-1,1-二氧化物 2-(3-甲氧基丙基)-4-氧代-3,4-二氢-2H-噻吩并[3,2-e][1,2]噻嗪-6-磺酰胺1,1-二氧化物 2,3-二氢-4H-噻吩并[2,3-e][1,2]噻嗪-4-酮1,1-二氧化物 1,5,6-三甲基-1,2,3,4-四氢-2LAMBDA6-噻吩并[2,3-C][1,2]噻嗪-2,2,4-三酮 (S)-6-氯-3,4-二氢-2H-噻吩[3,2-E]-1,2-噻嗪-4-醇 1,1-二氧化氮 (S)-6-氯-2-(3-甲氧基丙基)-3,4-二氢-2H-噻吩并[3,2-e][1,2]噻嗪-4-醇 1,1-二氧化物 (S)-3,4-二氢-4-羟基-2-(3-甲氧丙基)-2H-噻吩并[3,2-E]-1,2-噻嗪-6-磺酰胺 1,1-二氧化物 (4S)-3,4-二氢-2-(3-甲氧基丙基)-2H-噻吩并[3,2-e]-1,2-噻嗪-4-醇 1,1-二氧化物 2,3-dihydro-4H-thieno[2,3-e][1,3]thiazine-4-thione 3-(2-isobutylaminoethyl)-2,3-dihydro-4,4-dioxo-6-sulfamoyl-1H-thieno[2,3-b][1,4]thiazine hydrochloride (R)-3,4-dihydro-2-(4-methoxybutyl)-4-propylamino-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide (S)-N-(1,1-dimethylethyl)-3,4-dihydro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide N-(1,1-dimethylethyl)-2-[4-(4-morpholinyl)-2-butenyl]-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 3,4-Dihydro-4-hydroxy-N-(1,1-dimethylethyl)-2-[4-(4-morpholinyl)-2-butenyl]-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 6-chloro-3,4-dihydro-2-(4-bromobutyl)-2H-thieno[3,2-e]-1,2-thiazine-4-ol 1,1-dioxide 3,4-dihydro-2,6-dimethyl-3-oxo-2H-thieno[3,2-e]-1,2-thiazine-4-carboxanilide 1,1-dioxide (+)-4-Ethylamino-3,4-dihydro-2-methyl-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide (+)-4-Hydroxy-2-methyl-2,3-dihydro-4H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide 3,4-Dihydro-2-methyl-2H-thieno[3,2-e]-1,2-thiazine-4-ol-1,1-dioxide 3,4-Dihydro-4-hydroxy-2-(2-methoxy)ethyl-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide N-(1,1-Dimethylethyl)-3,4-dihydro-2-(4-methoxybutyl)-4-oxo-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 2,3-Dihydro-N-(1,1-dimethylethyl)-4-oxo-4H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide N-(2-dimethylaminoethyl)-6-ethyl-2,3-dihydro-1H-thieno[2,3-b][1,4]thiazine-1-carboxamide N-(1,1-Dimethylethyl)-3,4-dihydro-4-hydroxy-2-(4-methoxybutyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide (S)-N-(1,1-Dimethylethyl)-3,4-dihydro-4-hydroxy-2-(4-methoxybutyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 3,4-Dihydro-3-methyl-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide 2-methyl-3,4-dihydro-2H-thieno[2,3-e][1,2]thiazin-4-amine 1,1-dioxide 7-acetyl-1-phenyl-4H-thieno<2,3-b><1,2,4>triazolo<4,3-d><1,4>thiazine T 2097 3-Aethoxycarbonylmethyl-4-hydroxy-2-methyl-2H-thieno<2,3-e>-1,2-thiazin-1,1-dioxid 2-benzylthio-6-ethyl-3H-thieno<2,3-b><1,4>thiazine 2-[(4-methoxyphenyl)methyl]-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine 1,1-dioxide 3-[[Bis(2-methoxyethyl)amino]methyl]-2-ethyl-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 3-Hydroxymethyl-2-(1-methylethyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 3-[[(2-methoxyethyl)(3-methoxypropyl)amino]methyl]-2-methyl-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide 2-(Cyclopropylmethyl)-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1 dioxide 3-(4-Morpholinylmethyl)-2-propyl-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide